Action SUDARSHAN SUDARSHAN PHARMA INDUSTRIES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Sudarshan Pharma Industries Limited

Actions

SUDARSHAN

INE00TV01015

Marché Fermé - Bombay S.E.
Autres places de cotation
 12:00:57 04/07/2024 		Varia. 5j. Varia. 1 janv.
83,03 INR +2,10 % Graphique intraday de Sudarshan Pharma Industries Limited +1,26 % +2,14 %
27/05 Sudarshan Pharma Industries Limited nomme Nirav Shah secretaire de la societe a compter du 1er juin 2024 CI
01/04 Sudarshan Pharma Industries Limited annonce la démission d'Ishita Samani en tant que secrétaire de la société et responsable de la conformité CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Sudarshan Pharma Industries Limited Appoints Nirav Shah as the Company Secretary, Effective June 1, 2024
Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director
Sudarshan Pharma Industries Limited Announces Board Changes
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million.
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million.
Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Sudarshan Pharma Industries Limited has filed an IPO.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SUDARSHAN
  4. Actualités Sudarshan Pharma Industries Limited
  5. Autres langues